Retour sur lavenir.net
   RECTICEL 9.960 € (+0,20 %)     VGP 88.200 € (-0,68 %)     BEKAERT 41.600 € (-0,12 %)     AB INBEV 62.320 € (-2,38 %)     ARGENX SE 650.200 € (-2,31 %)     ATENOR 1.700 € (0,00 %)     AZELIS GROUP 11.100 € (-1,86 %)     UCB 224.700 € (-1,32 %)     KBC ANCORA 77.900 € (-0,13 %)     WDP 23.300 € (-2,35 %)     AGEAS 66.850 € (-0,89 %)     GBL 79.050 € (-0,75 %)     CENERGY 23.060 € (+4,91 %)     KBC 113.800 € (+0,31 %)     SYENSQO 55.900 € (+1,18 %)     SOFINA 217.400 € (-0,28 %)     AEDIFICA 71.700 € (-1,51 %)     LOTUS BAKERIES 10 160.000 € (+0,59 %)     ORANGE BELGIUM 21.000 € (0,00 %)     SHURGARD 25.850 € (-2,27 %)     MELEXIS 66.700 € (-4,51 %)     COFINIMMO 84.000 € (-1,23 %)     ONWARD MEDICAL 2.690 € (-4,61 %)     ACKERMANS V.HAAREN 274.400 € (-0,65 %)     ELIA GROUP 138.200 € (-0,58 %)     UMICORE 17.050 € (-0,87 %)     TUBIZE-FIN 190.900 € (-2,45 %)     MONTEA 70.000 € (-0,85 %)     CMB.TECH 11.440 € (+1,24 %)     CARE PROPERTY INV. 12.820 € (-0,47 %)     D'IETEREN GROUP 175.100 € (-0,79 %)     NYXOAH 2.500 € (-3,29 %)     SIPEF 99.400 € (-0,60 %)     TINC 11.880 € (-0,17 %)     PROXIMUS 6.500 € (-0,61 %)     DEME GROUP 186.400 € (-0,21 %)     GIMV 47.950 € (-0,31 %)     VIOHALCO 15.080 € (+1,89 %)     NYRSTAR 0.080 € (-2,20 %)     BARCO 9.450 € (-0,53 %)     SOLVAY 27.720 € (+1,46 %)     KINEPOLIS GROUP 30.750 € (-0,49 %)     FAGRON 23.850 € (+0,42 %)     ONTEX GROUP 2.920 € (-1,02 %)     COLRUYT 33.000 € (-0,42 %)     QRF 11.550 € (-2,12 %)     DECEUNINCK 2.170 € (+0,93 %)     BIOTALYS 2.910 € (-7,91 %)     VASTNED 29.500 € (-0,84 %)     BPOST 1.794 € (-1,97 %)     JENSEN-GROUP 70.000 € (-0,28 %)     CIE BOIS SAUVAGE 327.000 € (+0,62 %)     EXMAR 10.600 € (-0,93 %)     IBA 13.380 € (-1,33 %)     CAMPINE 219.000 € (+1,86 %)     TEXAF 43.800 € (-0,45 %)     BIOSENIC 0.002 € (0,00 %)     EVS BROADC.EQUIPM. 36.800 € (+2,08 %)     BANQUP GROUP 2.480 € (-1,20 %)     BREDERODE 102.600 € (-0,19 %)  
   FDJ UNITED 23.370 € (0,00 %)     BANIJAY GROUP 8.540 € (+0,23 %)     MAUNA KEA TECH 0.187 € (-0,43 %)     VIRIDIEN 144.300 € (-1,50 %)     CRCAM NORD CCI 28.010 € (-0,32 %)     NICOX 0.384 € (-2,78 %)     CVC CAPITAL 12.510 € (-0,32 %)     METAVISIO 0.001 € (-6,67 %)     EDP 4.591 € (-0,63 %)     ABIVAX 93.500 € (-2,15 %)     SOITEC 108.350 € (+9,71 %)     RUBIS 34.700 € (+0,75 %)     VALLOUREC 25.160 € (+1,00 %)     BUREAU VERITAS 25.880 € (+1,09 %)     CREDIT AGRICOLE 17.355 € (+0,26 %)     LVMH 447.350 € (-1,63 %)     BNP PARIBAS ACT.A 90.780 € (-0,81 %)     SCHNEIDER ELECTRIC 271.100 € (+0,11 %)     RANDSTAD NV 24.760 € (-1,67 %)     ADP 99.400 € (-8,30 %)     TECHNIP ENERGIES 40.700 € (+1,14 %)     CAPGEMINI 102.350 € (+3,09 %)     GALP ENERGIA-NOM 19.900 € (+1,30 %)     KPN KON 4.479 € (-3,20 %)     DASSAULT SYSTEMES 18.605 € (-1,01 %)     ESSILORLUXOTTICA 180.050 € (-1,45 %)     PHILIPS KON 21.910 € (-5,36 %)     WORLDLINE 0.267 € (-4,44 %)     SOLUTIONS 30 SE 0.609 € (-2,72 %)     ADYEN 952.800 € (-0,13 %)     PROSUS 40.420 € (-0,80 %)     ARCELORMITTAL SA 48.810 € (-1,03 %)     J.MARTINS,SGPS 20.160 € (-1,08 %)     ING GROEP N.V. 23.970 € (-0,19 %)     STMICROELECTRONICS 44.565 € (+5,62 %)     AIRBUS 174.360 € (+4,97 %)     BE SEMICONDUCTOR 239.800 € (+1,91 %)     EUROFINS SCIENT. 58.420 € (-2,24 %)     SHELL PLC 37.900 € (-0,14 %)     AYVENS 10.970 € (-0,72 %)     AXA 40.420 € (-1,37 %)     ASML HOLDING 1 185.000 € (+1,13 %)     SARTORIUS STED BIO 153.600 € (-2,04 %)     UBISOFT ENTERTAIN 4.861 € (-1,18 %)     UMG 19.425 € (+0,15 %)     SOCIETE GENERALE 71.180 € (+0,06 %)     IMCD 96.680 € (-0,96 %)     MOTA ENGIL 4.716 € (+0,86 %)     LEGRAND 149.000 € (+0,74 %)     SAFRAN 269.800 € (-0,55 %)     TELEPERFORMANCE 56.260 € (+3,99 %)     RELX 30.560 € (-0,97 %)     KERING 232.000 € (-1,74 %)     MICHELIN 31.210 € (-0,86 %)     DRONE VOLT 0.496 € (-11,43 %)     RENAULT 29.740 € (-1,43 %)     WOLTERS KLUWER 66.160 € (-0,42 %)     NEXANS 152.600 € (+3,11 %)     HEINEKEN 64.680 € (-3,17 %)     SOPRA STERIA GROUP 133.100 € (+16,75 %)  
News Réglementées
29/04/2026 14:00

ITALY AND SWITZERLAND: AN ALLIANCE FOR RESEARCH

EQS-News: Bracco SpA / Key word(s): Miscellaneous
ITALY AND SWITZERLAND: AN ALLIANCE FOR RESEARCH

29.04.2026 / 14:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


To mark Italian Research Day, Bracco Suisse hosted an event organized by the Consulate General of Italy in Geneva dedicated to the significant contributions made by Italian researchers at universities, research institutes, hospitals, and private companies in French-speaking Switzerland.

GENEVA, April 29, 2026 /PRNewswire/ -- Invited by the Consul General of Italy in Geneva, Nicoletta Piccirillo, the community of Italian researchers gathered at the Bracco Suisse headquarters in Plan-les-Ouates to celebrate the ninth Italian Research Day around the world.

Prof Minerva Becker - Consul General of Italy in Geneva Nicoletta Piccirillo - Vicepresident & CEO of Bracco Imaging Fulvio Renoldi Bracco - Prof Lucia Mazzolai (PRNewsfoto/Bracco SpA)

The Research Day takes place every year around this time to commemorate the birth on April 22 of Professor Rita Levi-Montalcini, winner of the 1986 Nobel Prize in Medicine and the first Italian woman to receive this award in the field of science.

The event was attended by about sixty specialists who shared their experiences and explored new opportunities for cooperation. The program emphasized innovation in health sciences.

In her remarks, the Consul General of Italy in Geneva, Nicoletta Piccirillo, highlighted the value of Italian Research Day as an occasion for celebration and well-deserved recognition for Italian researchers abroad: "This year, we are holding the event at a venue that symbolizes the value of Italian research. Bracco Imaging is a world-class leader in medical and scientific research, and the facility hosting us is the flagship of Italian research in Switzerland. The education received in Italy continues to serve as a solid foundation for successful careers also at the international level, as witnessed by the strong and extensive community of Italian researchers in French-speaking Switzerland."

Diana Bracco, Chairwoman and CEO of the Bracco Group, highlighted in a video message the fundamental role of the alliance between Switzerland and Italy in research: "Switzerland is of strategic importance to the Bracco Group. We have been present here for nearly 40 years: first with the Research Center and then, since 1997, with this site in Plan-les-Ouates, one of our largest production facilities. It is precisely the proximity of the R&D and production units—which we recently expanded based on criteria of efficiency and quality with an investment of over 80 million euros—that is an essential factor in Bracco's success in this extraordinary country. A choice in line with the strategic vision of our Group, which has always focused on research, seeking fertile and advanced territories in the field of innovation. The high-tech district of Plan-les-Ouates on the outskirts of the city is a cutting-edge ecosystem that perfectly embodies our mission, and we have always found exceptional partners in Italian and Swiss institutions."

In her presentation "From the Lab to the Patient: The Story of a Vessel That Can Change Lives," Professor Lucia Mazzolai, an expert in vascular medicine at the CHUV in Lausanne, highlighted the importance of bilateral collaboration in the health sciences:  "The treatment of lymphedema, for example, is entering a new phase of development: we are shifting from an approach focused on symptom management to one aimed at restoring function. In this process, engagement with Italian research is a key factor in consolidating and accelerating the progress achieved."

The event concluded with remarks by Fulvio Renoldi Bracco, Vice President and CEO of Bracco Imaging, who emphasized the importance of innovation for the benefit of patients: "Innovation plays a decisive role only when it addresses real clinical needs and improves patients' quality of life. It is not merely a technological matter, but the result of a human commitment driven by curiosity, rigor, and the ability to bridge different disciplines and institutions to achieve meaningful results and effective solutions. In this context, Bracco is proud to be at the forefront of medical imaging, supporting physicians, researchers, and the healthcare system with the goal of improving people's lives. The Geneva site is a global center of excellence with solutions already adopted in daily clinical practice for over two million patients a year and a robust pipeline that paves the way for the next generation of innovative products."

Media contact: 
Carolina Elefante - +39 02.21772279
M +39 333.4263484
Carolina.Elefante@bracco.com 

Photo - https://mma.prnewswire.com/media/2968963/Bracco.jpg
Logo - https://mma.prnewswire.com/media/1707756/Bracco_Logo.jpg

Bracco Logo (PRNewsfoto/Bracco Group)

Cision View original content to download multimedia:https://www.prnewswire.com/de/pressemitteilungen/italy-and-switzerland-an-alliance-for-research-302757185.html

rt.gif?NewsItemId=EN44071&Transmission_Id=202604290755PR_NEWS_EURO_ND__EN44071&DateId=20260429


29.04.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2317986  29.04.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière